PRIMECAP Management Bristol-Myers Squibb Co.

37 PRIMECAP Management Bristol-Myers Squibb Trades

PRIMECAP Management's position in Bristol-Myers Squibb is currently worth $1.43B. That's 0.88% of their equity portfolio (26th largest holding). The investor owns 1.23% of the outstanding Bristol-Myers Squibb stock. The first Bristol-Myers Squibb trade was made in Q1 2017. Since then PRIMECAP Management bought shares seventeen more times and sold shares on nineteen occasions. The stake costed the investor $1.42B, netting the investor a gain of 0.8% so far.

News about Bristol-Myers Squibb Co. and PRIMECAP Management

CIBC Asset Management Inc Sells 10,401 Shares of Bristol-Myers Squibb (NYSE:BMY)

CIBC Asset Management Inc reduced its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.7% in the 3rd quarter, according to the company in its most...

The AM Reporter, over 2 years ago

Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript)

Bristol-Myers Squibb Company (NYSE:NYSE:BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference January 4, 2024 11:00 AM ETCompany ParticipantsAdam…

Seeking Alpha, over 2 years ago

Dechtman Wealth Management LLC Trims Holdings in Bristol-Myers Squibb (NYSE:BMY)

Dechtman Wealth Management LLC decreased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 58.9% during the third quarter, according to the co...

The AM Reporter, over 2 years ago

Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS BioPharma Conference (Transcript)

Bristol-Myers Squibb Company (NYSE:NYSE:BMY) 2023 UBS BioPharma Conference Transcript November 8, 2023 8:00 AM ETExecutivesLynelle Hoch - Head, Cell…

Seeking Alpha, over 2 years ago